We are live on ! Find out more
HAE icon

Haemonetics

324 hedge funds and large institutions have $2.68B invested in Haemonetics in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $2.54M

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

4% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 55

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less funds holding

Funds holding: 328324 (-4)

6.15% less ownership

Funds ownership: 108.62%102.48% (-6.1%)

34% less capital invested

Capital invested by funds: $4.07B → $2.68B (-$1.39B)

Holders
324
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
57
Increased
117
Reduced
110
Closed
55
Calls
$6.75M
Puts
$2.54M
Net Calls
+$4.21M
Net Calls Change
-$59M
Name Holding Trade Value Shares
Change
Change in
Stake
Public Sector Pension Investment Board (PSP Investments)
101
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.24M
Envestnet Asset Management
102
Envestnet Asset Management
Illinois
$2.22M +$898K +13,792 +54%
Ameriprise
103
Ameriprise
Minnesota
$2.17M -$1.76M -27,042 -41%
HSBC Holdings
104
HSBC Holdings
United Kingdom
$2.1M +$1.71M +26,284 +240%
BIA
105
Beacon Investment Advisors
Maryland
$2.09M +$342K +5,253 +16%
State of New Jersey Common Pension Fund D
106
State of New Jersey Common Pension Fund D
New Jersey
$2.09M +$526K +8,078 +28%
EEL
107
Expect Equity LLC
Maryland
$2.09M +$368K +5,645 +18%
IIM
108
INTECH Investment Management
Florida
$1.86M +$934K +14,337 +77%
CIS
109
Connors Investor Services
Pennsylvania
$1.76M +$2.04M +31,282 New
QI
110
QV Investors
Alberta, Canada
$1.73M +$576K +8,850 +40%
QCM
111
Quantinno Capital Management
New York
$1.73M +$1.63M +25,000 +438%
EIP
112
Easterly Investment Partners
Massachusetts
$1.72M +$93.3K +1,432 +5%
Corient Private Wealth
113
Corient Private Wealth
Florida
$1.65M +$1.91M +29,304 New
Squarepoint
114
Squarepoint
New York
$1.65M +$1.91M +29,281 New
Russell Investments Group
115
Russell Investments Group
United Kingdom
$1.64M -$2.12M -32,544 -53%
MMEA
116
Main Management ETF Advisors
California
$1.6M +$1.85M +28,368 New
Barclays
117
Barclays
United Kingdom
$1.59M -$6.26M -96,076 -77%
Universal-Beteiligungs- und Servicegesellschaft
118
Universal-Beteiligungs- und Servicegesellschaft
Germany
$1.55M +$848K +13,022 +90%
Canada Life
119
Canada Life
Manitoba, Canada
$1.52M
LPL Financial
120
LPL Financial
California
$1.44M -$1.09M -16,702 -39%
GPGA
121
Grandeur Peak Global Advisors
Utah
$1.43M +$468K +7,192 +40%
DZ Bank
122
DZ Bank
Germany
$1.41M +$1.63M +25,071 New
CSP
123
Cary Street Partners
Virginia
$1.4M +$210K +3,231 +15%
KK
124
KLP Kapitalforvaltning
Norway
$1.39M +$931K +14,300 +139%
CCMINC
125
Cardinal Capital Management Inc (North Carolina)
North Carolina
$1.35M +$95K +1,458 +6%

HAE Hedge Fund Activity: Q1 2026 in Review

324 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2026, worth a combined $2.68B — down 34% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HAE positions and 55 closed out — a net gain of 2 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $43.3M. The largest seller was Holocene Advisors, cutting an estimated $82M.

  • 324 institutional investors held Haemonetics (HAE) as of Q1 2026, down from 328 in Q4 2025.
  • Funds reported $2.68B of Haemonetics stock for Q1 2026, down 34% quarter-over-quarter.
  • 57 funds opened new Haemonetics positions in Q1 2026 and 55 closed out, a net change of +2 holders.
  • The largest Haemonetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $43.3M added.
  • The largest Haemonetics seller in Q1 2026 was Holocene Advisors, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2026.